Literature DB >> 18356466

Arterial spin-labeling in routine clinical practice, part 3: hyperperfusion patterns.

A R Deibler1, J M Pollock, R A Kraft, H Tan, J H Burdette, J A Maldjian.   

Abstract

Arterial spin-labeled (ASL) perfusion imaging can be implemented successfully into a routine clinical neuroimaging protocol and can accurately demonstrate alterations in brain perfusion. We have observed patterns of focal, regional, and global hyperperfusion in a wide variety of disease processes. The causes of hyperperfusion at clinical ASL have not been previously characterized. Focal lesions such as brain tumors and vascular malformations with increased perfusion can be well depicted by ASL. More global causes of hyperperfusion, including postanoxia vasodilation and hypercapnia, may go undetected on conventional MR images, whereas the regional hyperperfusion, which may occur in reversible encephalopathies and luxury perfusion, has been consistently illustrated on ASL cerebral blood flow maps at our institution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18356466      PMCID: PMC3397396          DOI: 10.3174/ajnr.A1034

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  21 in total

1.  Susceptibility contrast and arterial spin labeled perfusion MRI in cerebrovascular disease.

Authors:  Ronald L Wolf; David C Alsop; Michael L McGarvey; Joseph A Maldjian; Jiongjiong Wang; John A Detre
Journal:  J Neuroimaging       Date:  2003-01       Impact factor: 2.486

2.  Neurogenic control of the cerebral circulation during global ischemia.

Authors:  M A Moskowitz; R Macfarlane; E Tasdemiroglu; E P Wei; H A Kontos
Journal:  Stroke       Date:  1990-11       Impact factor: 7.914

3.  Comparison of arterial spin-labeling techniques and dynamic susceptibility-weighted contrast-enhanced MRI in perfusion imaging of normal brain tissue.

Authors:  Marc-André Weber; Matthias Günther; Matthias P Lichy; Stefan Delorme; André Bongers; Christoph Thilmann; Marco Essig; Ivan Zuna; Lothar R Schad; Jürgen Debus; Heinz-Peter Schlemmer
Journal:  Invest Radiol       Date:  2003-11       Impact factor: 6.016

4.  Measurement of cerebral perfusion with arterial spin labeling: Part 2. Applications.

Authors:  Gregory G Brown; Camellia Clark; Thomas T Liu
Journal:  J Int Neuropsychol Soc       Date:  2007-05       Impact factor: 2.892

5.  Cerebral vascular response to hypercapnia: determination with perfusion MRI at 1.5 and 3.0 Tesla using a pulsed arterial spin labeling technique.

Authors:  Ulrike Nöth; Guy E Meadows; Futoshi Kotajima; Ralf Deichmann; Douglas R Corfield; Robert Turner
Journal:  J Magn Reson Imaging       Date:  2006-12       Impact factor: 4.813

Review 6.  Arterial spin-labeling in routine clinical practice, part 2: hypoperfusion patterns.

Authors:  A R Deibler; J M Pollock; R A Kraft; H Tan; J H Burdette; J A Maldjian
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 7.  Cerebrovascular complications in cancer patients.

Authors:  Lisa R Rogers
Journal:  Neurol Clin       Date:  2003-02       Impact factor: 3.806

Review 8.  The role of neuroeffector mechanisms in cerebral hyperperfusion syndromes.

Authors:  R Macfarlane; M A Moskowitz; D E Sakas; E Tasdemiroglu; E P Wei; H A Kontos
Journal:  J Neurosurg       Date:  1991-12       Impact factor: 5.115

Review 9.  Arterial spin-labeling in routine clinical practice, part 1: technique and artifacts.

Authors:  A R Deibler; J M Pollock; R A Kraft; H Tan; J H Burdette; J A Maldjian
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-27       Impact factor: 3.825

10.  Hyperperfusion encephalopathies: hypertensive encephalopathy and related conditions.

Authors:  Richard B Schwartz
Journal:  Neurologist       Date:  2002-01       Impact factor: 1.398

View more
  54 in total

1.  Arterial spin labelling: final steps to make it a clinical reality.

Authors:  Xavier Golay; Matthias Guenther
Journal:  MAGMA       Date:  2012-04       Impact factor: 2.310

2.  Flow-sensitive alternating inversion recovery (fair) imaging for retrograde cortical venous drainage related to intracranial dural arteriovenous fistula.

Authors:  Kyo Noguchi; Naoya Kuwayama; Michiya Kubo; Yuichi Kamisaki; Keisuke Kameda; Gakuto Tomizawa; Hideto Kawabe; Hikaru Seto
Journal:  Neuroradiology       Date:  2010-06-20       Impact factor: 2.804

3.  Arterial spin labeling in neuroimaging.

Authors:  Sasitorn Petcharunpaisan; Joana Ramalho; Mauricio Castillo
Journal:  World J Radiol       Date:  2010-10-28

Review 4.  Developmental venous anomalies of the brain in children -- imaging spectrum and update.

Authors:  Luke L Linscott; James L Leach; Blaise V Jones; Todd A Abruzzo
Journal:  Pediatr Radiol       Date:  2016-01-21

5.  Fully automated processing of fMRI data in SPM: from MRI scanner to PACS.

Authors:  Joseph A Maldjian; Aaron H Baer; Robert A Kraft; Paul J Laurienti; Jonathan H Burdette
Journal:  Neuroinformatics       Date:  2009-01-21

6.  Arterial spin labeling for acute stroke: practical considerations.

Authors:  Greg Zaharchuk
Journal:  Transl Stroke Res       Date:  2012-04-14       Impact factor: 6.829

Review 7.  Imaging of cerebral ischemia: from acute stroke to chronic disorders.

Authors:  May Nour; David S Liebeskind
Journal:  Neurol Clin       Date:  2013-10-23       Impact factor: 3.806

8.  Clinical profile of subdural hematomas: dangerousness of subdural subacute hematoma.

Authors:  E Kpelao; K A Beketi; A K Moumouni; A Doleagbenou; B Ntimon; P Egbohou; T Mouzou; K Tomta; D H Sama; A Abalo; A Walla; A Dossim
Journal:  Neurosurg Rev       Date:  2015-09-18       Impact factor: 3.042

Review 9.  Advanced MRI strategies for assessing spinal cord injury.

Authors:  Seth A Smith; James J Pekar; Peter C M van Zijl
Journal:  Handb Clin Neurol       Date:  2012

10.  Anoxic injury-associated cerebral hyperperfusion identified with arterial spin-labeled MR imaging.

Authors:  J M Pollock; C T Whitlow; A R Deibler; H Tan; J H Burdette; R A Kraft; J A Maldjian
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-01       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.